Arsenic trioxide versus tetraarsenic oxide in biomedical research: misunderstandings and misinterpretations
- 28 August 2011
- journal article
- Published by Springer Nature in BioMetals
- Vol. 25 (1) , 231-235
Abstract
This work presents an analytical chemist’s view on the sometimes unconscious use of arsenic trioxide in (bio)medical research. Arsenic trioxide is a frequently used chemical in cancer treatment research and its action to various malignant cells has been extensively studied and published. Unfortunately some research articles show trivial errors with regards to background knowledge of the chemical, handling the chemical, experimental design and interpretation of results like e.g. in a range of articles comparing advantages of tetraarsenic oxide over arsenic trioxide (dimeric/monomeric) although the dissolution of both yields the same active compound (HAsO2). To fully understand the implications of these errors we will highlight some of them with the intent to harmonize future work in this field.Keywords
This publication has 15 references indexed in Scilit:
- Antimony biomethylation in culture media revisited in the light of solubility and chemical speciation considerationsEnvironmental Toxicology, 2010
- Redox-Directed Cancer Therapeutics: Molecular Mechanisms and OpportunitiesAntioxidants & Redox Signaling, 2009
- Tetra-arsenic oxide (Tetras) enhances radiation sensitivity of solid tumors by anti-vascular effectCancer Letters, 2009
- Arsenic Chemistry2009
- Tetraarsenic Oxide-mediated Apoptosis in a Cervical Cancer Cell Line, SiHaCancer Research and Treatment, 2009
- Mineral Arsenicals in Traditional Medicines: Orpiment, Realgar, and ArsenoliteThe Journal of Pharmacology and Experimental Therapeutics, 2008
- Diarsenic and tetraarsenic oxide inhibit cell cycle progression and bFGF‐ and VEGF‐induced proliferation of human endothelial cellsJournal of Cellular Biochemistry, 2005
- Speciation of inorganic arsenic in some bottled Slovene mineral waters using HPLC–HGAFS and selective coprecipitation combined with FI-HGAFSWater Research, 2002
- Improved methods for investigating the external redox potential in hybridoma cell cultureCytotechnology, 1996
- Cellular uptake and metabolic reduction of pentavalent to trivalent arsenic as determinants of cytotoxicity and morphological transformationCarcinogenesis, 1987